Cerebrospinal fluid (2) Models (2) temps (durée) (1) thérapie (1) norme (1) risque (1) association (1) lumière (1) hôpital (1) analyse (1) évaluation (1) enzyme (1) maladie (1) comparaison (1) maladie cardiovasculaire (1) biomarqueur (1) Bâle (1) Diagnosis (1) Comparison (1) Treatment (1) Methods (1) Apolipoprotein E (1) Phospholipase A2 (1) Value (1) Time (1) Therapeutics (1) Stairs (1) Social groups (1) Serum (1) Risk (1)